Author Archives: czbiomed_t0k2xz

Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment

Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment Well Marker Bio Co. Ltd., a biotech division of Asan Medical Center of South Korea, signs Memorandum of Understanding with CZ Biomed Corp. and Kocal … Continue reading

Posted in Uncategorized | Leave a comment

Partnerships with Bio-pharmaceutical Leaders

Kocal Consulting Corporation Celebrates new Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-pharmaceutical World Bio-pharmaceutical insiders have long known about the important, diverse work being done by CZ Biomed Corp, some of which could have … Continue reading

Posted in Cancer News, Colon Cancer, Prostate Cancer | Leave a comment

Oncolytic Virus Reduces Prostate Cancer

Oncolytic Virus Genetically Engineered from “Respiratory Syncytial Virus” (RSV) Reduces Prostate Cancer Tumors More Than 50% Press Release CZ BioMed Corp. Announces Successful Reduction of Prostate Cancer Tumors More Than 50% Using PRO-RVLYSIS(R) TAMPA, FL, August 26, 2013 – CZ … Continue reading

Posted in Prostate Cancer | Leave a comment

Oncolytic Virus Success Treating Colon Cancer

Oncolytic Virus “Respiratory Syncytial Virus” (RSV) Genetically Engineered to Treat Various Cancers Shows Stunning Results in Treating Colon Cancer Press Release – November 11, 2015 CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient. Cancer Free … Continue reading

Posted in Colon Cancer | Leave a comment